文献速递泌尿生殖胸部神经CT

间变性前列腺癌远处转移的模式与分布:单中心101例经验

Pattern and Distribution of Distant Metastases in Anaplastic Prostate Carcinoma: A Single-Institute Experience With 101 Patients.
PubMed 文献 · AJR Am J Roentgenol · 2017-06-07

回顾性分析101例间变性前列腺癌患者化疗前CT与骨扫描,83例(82%)有骨转移,其中23例(28%)PSA正常(<4 ng/mL);63例(62%)有非骨性远处转移,常见部位为肝、肺、纵隔、胸膜、脑和肾上腺;作者认为PSA不可靠,建议无论PSA水平如何,常规分期和随访均应考虑胸腹盆CT。

要点

  • 间变性前列腺癌骨转移率82%(83/101),非骨性远处转移率62%(63/101)。
  • 骨转移患者中28%(23/83)PSA正常(<4 ng/mL)。
  • 非骨性转移患者中41%(26/63)PSA正常(<4 ng/mL)。

核心结论

  • 间变性前列腺癌患者典型和非典型转移部位发生率高;非骨性远处转移常见于肝、肺、纵隔、胸膜、脑和肾上腺;PSA水平不可靠且可能不成比例地低,即使存在多灶大体积转移;作者建议无论PSA水平如何,常规分期和随访均应考虑胸腹盆CT。

研究设计与样本

  • 单中心回顾性研究,纳入101例间变性前列腺癌患者,在铂类化疗前接受CT和骨扫描,回顾性分析CT转移部位并与基线PSA水平进行相关性分析。

关键影像表现/征象

  • 骨转移83/101例(82%),非骨性远处转移63/101例(62%)。
  • 非骨性转移部位:肝34例、纵隔31例、肺24例、脑9例、胸膜7例、肾上腺6例、腹膜4例、脾1例。
  • 骨转移患者PSA水平显著高于无骨转移患者。
  • 骨转移类型(成骨型 vs 溶骨型)与PSA水平无统计学显著相关性。
  • 非骨性远处转移患者PSA水平未显著升高。

诊断标准与关键数值

  • PSA正常范围定义为<4 ng/mL。
  • 骨转移患者中28%(23/83)PSA<4 ng/mL。
  • 非骨性转移患者中41%(26/63)PSA<4 ng/mL。

临床应用与阅片要点

  • 作者建议间变性前列腺癌患者常规分期和随访中考虑胸腹盆CT,无论PSA水平如何。
  • 骨转移患者中28%PSA正常,非骨性转移患者中41%PSA正常,PSA水平不可靠。
  • 骨转移类型(成骨型 vs 溶骨型)与PSA水平无统计学显著相关性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to evaluate the sites and frequencies of distant metastases in patients with anaplastic prostate carcinoma and to correlate those findings with prostate-specific antigen (PSA) levels.

MATERIALS AND METHODS: Patients with anaplastic prostate carcinoma (n = 101) underwent CT and bone scans before platinum-based chemotherapy. CT findings were retrospectively reviewed to identify the sites of metastases. CT findings were correlated with baseline PSA levels. The Wilcoxon rank sum test was used to correlate PSA levels between patients with metastases at osseous and nonosseous sites. The Wilcoxon rank sum test was also used to correlate the type of bone metastases (blastic vs lytic) and the PSA levels.

RESULTS: Eighty-three of 101 patients (82%) had osseous metastases. PSA levels were significantly higher in patients with bone metastases than in patients without osseous metastases. However, 23 of the 83 patients (28%) with bone metastases had PSA levels in the normal range (i.e., < 4 ng/mL). The type of bone metastases (blastic vs lytic) did not show any statistically significant correlation to the PSA levels. Overall, 63 of 101 patients (62%) had nonosseous distant metastases at one or more sites, including the liver (n = 34), lung (n = 24), mediastinum (n = 31), pleura (n = 7), brain (n = 9), adrenal glands (n = 6), peritoneum (n = 4), and spleen (n = 1). PSA levels were not significantly elevated in patients with nonosseous distant metastases. Twenty-six of the 63 patients (41%) with nonosseous metastases had PSA levels in the normal range (< 4 ng/mL).

CONCLUSION: Patients with the anaplastic clinical variant of prostate cancer have a high frequency of typical and atypical sites of metastases. Common sites of nonosseous distant metastases include the liver, lung, mediastinum, pleura, brain, and adrenal glands. PSA levels are unreliable and may be disproportionately low, despite the presence of multifocal large-volume metastases. CT of the chest, abdomen, and pelvis should be considered in routine staging and follow-up of patients with anaplastic prostate carcinoma regardless of their PSA levels.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Ganeshan D, Aparicio AM, Morani A, et al. Pattern and Distribution of Distant Metastases in Anaplastic Prostate Carcinoma: A Single-Institute Experience With 101 Patients. AJR Am J Roentgenol. 2017. PMID: 28590819. doi:10.2214/AJR.16.17214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。